Cleaved SLPI as a marker for exacerbation in cystic fibrosis

Matthew Twigg (Belfast, United Kingdom), Matthew Twigg, Simon Brockbank, Philip Lowry, Peter FitzGerald, Sinéad Weldon, Clifford Taggart

Source: International Congress 2015 – Systemic and airway biomarkers
Session: Systemic and airway biomarkers
Session type: Thematic Poster Session
Number: 3876
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Matthew Twigg (Belfast, United Kingdom), Matthew Twigg, Simon Brockbank, Philip Lowry, Peter FitzGerald, Sinéad Weldon, Clifford Taggart. Cleaved SLPI as a marker for exacerbation in cystic fibrosis. Eur Respir J 2015; 46: Suppl. 59, 3876

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015



Neutrophil elastase degraded elastin is elevated in serum of idiopathic pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014


Inflammatory biomarkers in urine of cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014


Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014

Regulation of WISP1 by profibrotic cytokines in pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014

Severe lung inflammation is a feature of IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Assessment of oxidative stress in cystic fibrosis using malondialdehyde
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Novel protein biomarkers of bronchiectasis in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Antiviral activity of azithromycin in cystic fibrosis airway epithelial cells
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014


Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Elevation of serum napsin A in interstitial lung diseases in comparison with KL-6 and surfactant protein-D
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
Source: International Congress 2014 – IPF and surroundings
Year: 2014



Adaptation of prevotella during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Ability of the lung clearance index to detect inflammation and infection in preschool children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015

Non-invasive evaluation of airway inflammation in non-CF bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016

Mucus production, lung inflammation and functional decay in IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Angiopoietin-2 gene polymorphism as prognostic factor in caucasians with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 1
Year: 2014